Stay updated on Nivolumab in Esophageal Squamous Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Esophageal Squamous Cell Carcinoma Clinical Trial page.

Latest updates to the Nivolumab in Esophageal Squamous Cell Carcinoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2 and removed the prior government-funding notice (Revision: v3.4.1) from the page.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a government funding lapse notice affecting site status and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedGlossary display has been added and the 'Last Update Submitted that Met QC Criteria' field is now shown. The 'No FEAR Act Data' notice has updated capitalization and the page revision changed from v3.3.4 to v3.4.0.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. This update does not modify study content, eligibility criteria, or results.SummaryDifference0.1%

- Check64 days agoChange DetectedA consolidated 'Locations' section has been added listing California, New York, and Oregon, replacing the previous separate location headings; the revision note indicates v3.3.3.SummaryDifference0.4%

- Check85 days agoChange DetectedThe page shows a new revision label v3.3.2 added and the previous v3.3.1 removed, indicating a minor update to the document. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab in Esophageal Squamous Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Esophageal Squamous Cell Carcinoma Clinical Trial page.